Lorfast Meltab Tablet contains Loratadine 10 mg, a second-generation antihistamine used primarily for the relief of allergic symptoms. Loratadine exerts its effect by selectively inhibiting peripheral H1 histamine receptors, thereby reducing the typical manifestations of allergic reactions such as sneezing, rhinorrhea, nasal congestion, and pruritus associated with allergic rhinitis. Additionally, it is effective in managing chronic idiopathic urticaria by alleviating symptoms like itching and hives. Lorfast Meltab is formulated as an orally disintegrating tablet, facilitating ease of administration without the need for water, which enhances patient compliance, especially in pediatric and geriatric populations. The medication demonstrates minimal sedative effects due to its limited penetration of the blood-brain barrier, making it suitable for daytime use. It is rapidly absorbed, with onset of action typically within 1 to 3 hours, and a duration of effect lasting up to 24 hours, allowing once-daily dosing. Lorfast Meltab should be used as directed by a healthcare professional, and caution is advised in patients with hepatic impairment. It is contraindicated in individuals with known hypersensitivity to Loratadine or any tablet components. Common adverse effects are generally mild and may include headache, fatigue, and dry mouth.